291 related articles for article (PubMed ID: 36483553)
1. Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma.
Fan T; Lu J; Niu D; Zhang Y; Wang B; Zhang B; Zhang Z; He X; Peng N; Li B; Fang H; Gong Z; Zhang L
Front Immunol; 2022; 13():1046121. PubMed ID: 36483553
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.
Lu H; Qian J; Cheng L; Shen Y; Chu T; Zhao C
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38081768
[TBL] [Abstract][Full Text] [Related]
3. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
Zhang P; Liu J; Pei S; Wu D; Xie J; Liu J; Li J
Front Immunol; 2023; 14():1189520. PubMed ID: 37256127
[TBL] [Abstract][Full Text] [Related]
4. Single-cell dissection reveals the role of aggrephagy patterns in tumor microenvironment components aiding predicting prognosis and immunotherapy on lung adenocarcinoma.
Sun X; Meng F; Nong M; Fang H; Lu C; Wang Y; Zhang P
Aging (Albany NY); 2023 Dec; 15(23):14333-14371. PubMed ID: 38095634
[TBL] [Abstract][Full Text] [Related]
5. Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cells.
Zhang H; Zhang P; Lin X; Tan L; Wang Y; Jia X; Wang K; Li X; Sun D
Front Immunol; 2024; 15():1366096. PubMed ID: 38596689
[TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma.
Lin S; Zhou S; Han X; Yang Y; Zhou H; Chang X; Zhou Y; Ding Y; Lin H; Hu Q
Aging (Albany NY); 2023 Oct; 15(20):11508-11531. PubMed ID: 37878007
[TBL] [Abstract][Full Text] [Related]
7. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
[TBL] [Abstract][Full Text] [Related]
8. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.
Chen Z; Huang Y; Hu Z; Zhao M; Li M; Bi G; Zheng Y; Liang J; Lu T; Jiang W; Xu S; Zhan C; Xi J; Wang Q; Tan L
Clin Transl Med; 2021 Mar; 11(3):e350. PubMed ID: 33783985
[TBL] [Abstract][Full Text] [Related]
9. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
10. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
Wu X; Wang S; Chen K
Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
[TBL] [Abstract][Full Text] [Related]
11. Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort.
Li R; Tong R; Zhang Z; Deng M; Wang T; Hou G
Genomics; 2022 Nov; 114(6):110520. PubMed ID: 36372305
[TBL] [Abstract][Full Text] [Related]
12. Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.
Tang L; Chen Z; Yang J; Li Q; Wang S; Mo T; Zeng W; Ding H; Pan S
Front Immunol; 2024; 15():1352893. PubMed ID: 38390340
[TBL] [Abstract][Full Text] [Related]
13. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.
He D; Tang H; Yang X; Liu X; Zhang Y; Shi J
Front Immunol; 2023; 14():1278496. PubMed ID: 37965333
[TBL] [Abstract][Full Text] [Related]
14. By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma.
Zhang P; Pei S; Gong Z; Feng Y; Zhang X; Yang F; Wang W
Front Immunol; 2023; 14():1115272. PubMed ID: 36776843
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.
Mao S; Wang Y; Chao N; Zeng L; Zhang L
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38616208
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of lung adenocarcinoma based on cancer-associated fibroblasts genes using scRNA-sequencing.
Zhang H; Wang Y; Wang K; Ding Y; Li X; Zhao S; Jia X; Sun D
Aging (Albany NY); 2023 Jul; 15(14):6774-6797. PubMed ID: 37437244
[TBL] [Abstract][Full Text] [Related]
17. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes in lung adenocarcinoma cells using single-cell RNA sequencing not detected using traditional RNA sequencing and microarray.
Chen Z; Zhao M; Li M; Sui Q; Bian Y; Liang J; Hu Z; Zheng Y; Lu T; Huang Y; Zhan C; Jiang W; Wang Q; Tan L
Lab Invest; 2020 Oct; 100(10):1318-1329. PubMed ID: 32327726
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis reveals intratumoral heterogeneity in lung adenocarcinoma.
Xu H; Jiang L; Qin L; Shi P; Xu P; Liu C
Environ Toxicol; 2024 Mar; 39(3):1847-1857. PubMed ID: 38133212
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the potential of senescence-related genes in guiding clinical therapy of lung adenocarcinoma patients.
Liu C; Wei X
Funct Integr Genomics; 2023 May; 23(2):188. PubMed ID: 37246190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
